| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.600 | None | 0.956 | 1 | 0 | 1999 | 2020 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.600 | None | 0.844 | 1 | 0 | 1994 | 2020 | ||||||||
|
integrin subunit beta 3 | 0.485 | 0.846 | 1.7E-03 |
|
group | 0.590 | None | 1.000 | 1 | 0 | 1998 | 2019 | ||||||||
|
integrin subunit alpha 2b | 0.493 | 0.692 | 1.5E-16 |
|
group | 0.570 | None | 0.667 | 1 | 0 | 1997 | 2017 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
group | 0.570 | None | 0.889 | 1 | 0 | 1999 | 2019 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
group | 0.560 | None | 1.000 | 1 | 0 | 1999 | 2018 | ||||||||
|
endothelin receptor type A | 0.426 | 0.885 | 0.99 |
|
group | 0.510 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
group | 0.400 | None | 0.933 | 2 | 0 | 1998 | 2019 | ||||||||
|
arachidonate 5-lipoxygenase activating protein | 0.612 | 0.731 | 7.1E-02 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 2004 | 2018 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
group | 0.360 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2014 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
group | 0.300 | None | 1.000 | 2 | 0 | 2001 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.300 | None | 0.976 | 2 | 0 | 2003 | 2019 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
group | 0.300 | None | 0.933 | 1 | 0 | 2005 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
phosphodiesterase 4D | 0.519 | 0.846 | 1.00 |
|
group | 0.300 | None | 0.953 | 1 | 0 | 2002 | 2018 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.300 | None | 0.958 | 1 | 0 | 2001 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.300 | None | 0.977 | 1 | 0 | 1999 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
group | 0.300 | None | 0.917 | 1 | 0 | 2003 | 2020 | ||||||||
|
angiopoietin 1 | 0.446 | 0.808 | 0.95 |
|
group | 0.290 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
group | 0.290 | None | 0.900 | 1 | 0 | 2001 | 2018 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
group | 0.290 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
nerve growth factor | 0.391 | 0.885 | 0.82 |
|
group | 0.290 | None | 1.000 | 1 | 0 | 2001 | 2020 | ||||||||
|
adrenomedullin | 0.436 | 0.808 | 4.1E-02 |
|
group | 0.270 | None | 1.000 | 1 | 0 | 2004 | 2019 |